Associate or full Professor WOT, Department of Pediatrics, Center of Respiratory Biology and Therapeutics

Description

The Department of Pediatrics at the University of Washington School of Medicine, in partnership with Seattle Children's Hospital are seeking a full-time or at a minimum 0.75 part-time faculty member at the rank of Associate Professor, without tenure by reason of funding, or full Professor, without tenure by reason of funding, on the faculty-scientist track. Successful candidates will be expected to generate additional funding through clinical activities. This individual will have the role of Clinical Studies Medical Director of the Cystic Fibrosis Therapeutics Development Network Coordinating Center (CF TDNCC) at Seattle Children’s Research Institute, in the Center of Respiratory Biology and Therapeutics.

The successful candidate will be expected to engage in basic and translational research, as well as study design and clinical outcomes research.

Please be advised that part-time positions are not eligible for visa sponsorship or permanent residence sponsorship by the University of Washington.

The base salary range for this position will be: Associate Professors  $18,500 - $26,662 per month ($222,000- $319,944 annually), Professors $22,334 - $34,167 per month ($268,008 - $410,004 annually) commensurate with experience and qualifications, or as mandated by a U.S. Department of Labor prevailing wage determination.  This range is inclusive of base salary provided through the Children’s University Medical Group (CUMG) practice plan, in addition to base salary provided by the University. Please note that only compensation provided by the University is included in University benefit determinations and calculations. Compensation provided by Children’s University Medical Group (CUMG) practice plan may provide eligibility for separate benefits offered by that organization.

Other compensation associated with this position may include incentive through Children’s University Medical Group practice plan. Additional administrative responsibilities may be offered to a specific candidate with appropriate experience and qualifications which may result in an administrative supplement (ADS).

Associate and full Professors hold indefinite appointments that align with a 12-month service period (July 1-June 30).  Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

All University of Washington faculty engage in teaching, research and service.

Anticipated start date is Summer 2025.

Responsibilities

·      CF TDNCC Clinical Studies Medical Director provides direction of and will run the Medical Monitoring program supporting multicenter CF studies coordinated through the CF TDNCC, with responsibilities including assisting with back up for core medical monitor team, reviewing safety reporting, providing advice for challenging adverse event reports and interpretation of those events, running annual medical monitor training and leading calls with medical monitors regarding new studies. This also includes recruiting physician providers to participate in the 24 hr/7 day a week coverage schedule.

·        CF TDNCC Clinical Studies Medical Director is a key member of the TDNCC leadership team working with the Co-Executive Directors to develop strategic initiatives and growth plans specific for the TDNCC to support a pipeline of CF multicenter studies, and will work with the Co-Executive Directors and Business Operations Director to develop models for financial stewardship. 

·         CF TDNCC Clinical Studies Medical Director will lead the inception, submission, and execution as a PI of grants to both the NIH and CFF for large multicenter studies to support the TDNCC and advance the mission of the TDN.

·        CF TDNCC Clinical Studies Medical Director will collaborate with managers, directors, and supervisors of the CF TDNCC to build a cohesive leadership team and will participate in the oversight of TDNCC studies.

·        CF TDNCC Clinical Studies Medical Director will partner with external investigators to ensure successful coordination of their studies within the CF TDNCC.

·        CF TDNCC Clinical Studies Medical Director will be a member of the advisor team for the TDN’s Industry Consulting Program, evaluating clinical development packages and providing input on both scientific merit and feasibility.

·        CF TDNCC Clinical Studies Medical Director will serve on key advisory committees for the TDN, including the Clinical Research Executive Committee.

·        CF TDNCC Clinical Studies Medical Director will report directly to both the Co-Executive Directors of the CF TDNCC and the appropriate Division Head of their clinical specialty.

·<